Dr. Green is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave A840
San Francisco, CA 94143Phone+1 415-353-2273Fax+1 415-353-2898
Education & Training
- University of California (San Francisco)Residency, Neurology, 2002 - 2005
- University of California (San Francisco)Internship, Internal Medicine, 2001 - 2002
- Duke University School of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2003 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis Start of enrollment: 2014 Jan 01
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) Start of enrollment: 2017 Feb 28
Publications & Presentations
PubMed
- 14 citationsAssociation between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, pl...Jeffrey L Bennett, Orhan Aktas, William A Rees, Michael A Smith, Michele Gunsior
Ebiomedicine. 2022-12-01 - 1 citationsRetinal arteriolar parameters as a surrogate marker of intracranial vascular pathology.Ahmed Abdelhak, Isaac Solomon, Shivany Condor Montes, Alexandra Saias, Christian Cordano
Alzheimer's & Dementia. 2022-01-01 - 26 citationsValidating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy.Christian Cordano, Jung H Sin, Hao H Yiu, Karin Stebbins, Caroline Guglielmetti
Brain. 2022-11-21
Journal Articles
- Chronic Meningitis Investigated via Metagenomic Next-Generation SequencingJonathan H Blum, Luke Strnad, Leonard H Calabrese, John P Betjemann, Maulik P Shah, Felicia C Chow, Mark P Gorman, John E Greenlee, Michael R Wilson, Megan B Richie, W..., JAMA
- Systematic Integration of Biomedical Knowledge Prioritizes Drugs for RepurposingAri Green, Dexter Hadley, eLife
Press Mentions
- New Treatment May Stop and Potentially Reverse Some Nerve Damage in MSAugust 9th, 2024
- Could This New Drug Turn Back the Clock on Multiple Sclerosis?August 6th, 2024
- An Antihistamine Showed Promise for Reversing MS. Could They Prove It?February 14th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: